Gena Health offers an agentic workspace designed for precision oncology, enabling oncologists to integrate genomic data, clinical records, and AI-driven decision support within a single platform.
Funding
Funding not disclosed
Founders
Product
Problem
Oncologists often must manually gather and reconcile genomic data, electronic health records, and multidisciplinary inputs, which is time‑consuming and prone to errors, delaying the selection of optimal targeted cancer therapies.
Solution
Gena Health provides an agentic workspace that unifies a patient’s molecular profile, clinical records, and AI‑driven decision support into a single interface. The platform enables real‑time collaboration among oncologists, pathologists, and other specialists, allowing them to co‑author treatment plans based on the latest evidence. Integrated AI tools prioritize actionable variants, suggest FDA‑approved or clinical‑trial options, and automate routine documentation. By centralizing data and streamlining workflows, the solution reduces manual effort and accelerates the delivery of personalized oncology care.
Target Audience
Primary users are oncologists, molecular tumor board members, and precision‑medicine teams within hospitals, cancer centers, and specialty clinics.
Features
- Unified dashboard that aggregates genomic sequencing results, pathology reports, and EHR data for each patient
- AI-powered variant interpretation that highlights clinically actionable mutations and recommends targeted therapies or trial enrollments
- Collaborative workspaces with role‑based access, enabling multidisciplinary teams to comment, annotate, and approve treatment plans within the platform
- Automated generation of molecular tumor board reports and treatment summaries that integrate directly with existing EHR systems
- Real‑time alerts for new evidence, guideline updates, or trial eligibility changes relevant to a patient’s molecular profile